Tuija Väänänen

YKL-40 as a Novel Factor Associated with Inflammation and Catabolic Mechanisms in Osteoarthritic Joints

Tuija Väänänen, Anna Koskinen, Erja‐Leena Paukkeri et al. · Mediators of Inflammation · 2014 · 66 citations · Full text

Immunology, Pathology, Osteoporosis +22

Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial

Tuija Väänänen, Katriina Vuolteenaho, Hannu Kautiainen et al. · PLoS ONE · 2017 · 39 citations · Full text

Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects

Tuija Väänänen, Lauri Lehtimäki, Katriina Vuolteenaho et al. · Mediators of Inflammation · 2017 · 15 citations · Full text

High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker

Tuija Väänänen, Jukka Kallio, Katriina Vuolteenaho et al. · Scandinavian Journal of Urology · 2017 · 12 citations · Full text